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Background: The Global Campaign against Headache has pioneered evaluation of the prevalence and impact of
headache on the preceding day (“headache yesterday”) as a new approach to the estimation of headache-
attributed burden, avoiding recall error. We report its application in Karnataka State, southern India.
Methods: In a door-to-door survey, biologically unrelated adults (aged 18–65 years) were randomly sampled from
urban and rural areas in and around Bengaluru and interviewed by trained researchers using a validated, structured
questionnaire. Enquiry into headache applied ICHD-II diagnostic criteria and included questions about headache on
the day preceding the interview (headache yesterday [HY]).
Results: There were 2329 participants (participation proportion 92.6 %; males 1141 [49.0 %], females 1188 [51.0 %];
mean age 38.0 [±12.7] years; 1103 [47.4 %] from rural areas, 1226 [52.6 %] urban). HY was reported by 138
participants (males 33 [2.9 %], females 105 [8.8 %]): the 1-day prevalence of headache was 5.9 %. Mean duration of
HY was 7.0 ± 8.5 h, so that 1.7 % of the population (5.9 % * 7.0/24), on average, had headache at any moment in
time yesterday. Mean intensity on a scale of 1–3 was 2.0 [±0.8]. Lost productivity due to HY was reported by 83.3 %
of participants with HY: 37.7 % able to do less than half of what they had planned and 13.0 % able to do nothing.
Productivity loss at population level (being the productivity loss within the entire adult population, every single day,
attributable to headache) was 3.0 %.
Conclusions: This method of enquiry, free from recall error, confirmed a very high level of headache-attributed
burden in Karnataka: previous estimates based on 3-month recall may even have been too low. Until another study
is done in the country, these are the best data for all India. They demonstrate need for action nationwide to
mitigate this burden, and correct action will ultimately almost certainly be cost-saving.
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The very heavy disability burden attributable to head-
ache disorders is becoming increasingly clear [1, 2]. The
Global Burden of Disease Study 2010 (GBD2010) ranked
tension-type headache (TTH) and migraine as the sec-
ond and third most common diseases worldwide [3], but
many of the data included in this world survey derived
from heterogeneous studies performed with varying
methods over a period of nearly 30 years. In all regions
except the Far East, more recent studies–of migraine in* Correspondence: t.steiner@imperial.ac.uk
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mates than the global mean estimates of GBD2010 [3]
or GBD2013 [1]. This has been particularly apparent in
low- and lower-middle-income countries: Georgia [4],
India [5], Nepal [6], Zambia [7], Ethiopia (unpublished)
and Pakistan (unpublished). In part this is explained by
the careful methodology of recent studies [8, 9]. To a
greater extent it may be because many earlier published
studies excluded probable migraine: many reports are
silent on how ICHD diagnostic criteria were applied
with respect to definite and probable migraine; some
explicitly excluded the latter, but a larger number may
have done so without making this clear.is distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
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Headache [10, 11] continues its drive to conduct
population-based studies in those parts of the world
where data are currently lacking–mostly in low- and
lower-middle-income countries, is that global mean
prevalence estimates will continue to rise. With them,
estimates of burden will rise also, as they have done
through the iterative GBD studies since 2000 [2]. These
estimates are the basis of needs assessments informing
health policy and allocation of health-care resources.
When disease burdens are large and the call upon re-
sources is substantial, estimates need to be as accurate
as possible. The methodology for measuring headache-
attributed burden is a relatively new and still developing
science [8, 9]: in the last 30 years, many population-
based studies of headache have assessed prevalence only.
It is a field of innovation to which Lifting The Burden
(LTB) [12, 13] has actively contributed in leading the
Global Campaign against Headache. The components of
headache-attributed burden are wide-ranging, and some
are challenging to measure [9]. Symptom burden can be
measured in terms of frequency, intensity and duration.
The GBD studies use frequency and duration to estimate
the proportion of time spent with symptoms, and apply
a disability weight to this proportion of time to calculate
the associated health loss [3]. For socioeconomic impact,
the Headache-Attributed Lost Time (HALT) Index [14]
enquires into effect of headache on productivity. In its
original form (HALT-90), it relied upon a respondent’s
recall over the 3 months prior to the interview, that
period of enquiry being intended to gather a representa-
tive view of each participant’s lost productive time. This
approach has its uses, but is subject to the limitations,
errors and possible biases of recall over such a long
period.
LTB has pioneered an alternative approach to avoid
the problems associated with recall error, which is en-
quiry into headache occurring on the day before the
interview (“headache yesterday”; HY) [8]. Recollection of
HY, its symptoms and whatever impact they may have
had, is likely to be highly reliable. While what happened
yesterday is not representative, or therefore indicative, of
an individual’s headache-attributed burden over longer
periods of time, at population level it is. This approach
does, however, require a large number of participants,
since far fewer people have headache in 1 day than in 3
months.
A question subset concerning HY [9] has been in-
cluded in several recent large epidemiological studies
supported by LTB within the Global Campaign against
Headache: in China [15], Russia [16], countries of the
Eurolight project [17] and several others not yet pub-
lished. Here we report the analysis of HY in Karnataka
State, southern India, and make comparisons withestimates based on 3 months’ recall [18]. We apply the
analysis in making an estimate of socioeconomic burden
attributable to headache disorders in Karnataka State,
and consider extrapolating this to all India.
Methods
The methods of the study have been published in detail
previously [19] and are described only briefly here.
Study design and sampling
This was a cross-sectional survey, conducted during
May to November 2009. It sampled urban and rural
areas in and around Bengaluru: Kempegowdanagara, an
urban administrative ward in the city of Bengaluru, and
Uyamballi and Doddaaladahalli, two large villages lo-
cated 75–80 Km from Bengaluru. Trained interviewers
selected households randomly through multistage cluster
sampling. They called at each household unannounced,
listed all adult members (aged 18–65 years), randomly
selected one and interviewed that person.
Enquiry and diagnosis
The survey instrument was a cultural adaptation of
LTB’s structured HARDSHIP questionnaire [9], trans-
lated into the local language (Kannada) in accordance
with LTB’s translation protocol for hybrid documents
[20], and validated [19]. It began with demographic en-
quiry. The headache screening question (“Have you had
headache during the last year?”) and diagnostic ques-
tions based on ICHD-II [21] were followed, for those
reporting headache, by multiple question sets enquiring
into various aspects of burden, including the HALT
questionnaire [14]. Participants reporting more than one
headache type were asked to focus only on the one that
was subjectively the most bothersome for purposes of
diagnosis and burden attribution.
Diagnoses were made algorithmically. Participants
with headache on ≥15 days/month were first identified;
among these, any with medication overuse were diag-
nosed as probable MOH (pMOH), the remainder as
“other headache on ≥15 days/month”. The algorithm
then applied ICHD-II criteria to all other cases in hier-
archical sequence: first for definite migraine, then for
definite TTH, then for probable migraine and finally for
probable TTH. Remaining cases were considered unclas-
sifiable. In the analysis, definite migraine and probable
migraine were grouped as migraine, and definite TTH
and probable TTH as TTH.
Questions on HY (in response to “Did you have head-
ache yesterday?”) included duration of HY (in hours up
to 24), intensity of HY (reported by participants on a
three-point categorical score [“not bad”, “quite bad” and
“very bad”]) and usage of acute medications. Lost prod-
uctivity because of HY was reported as what had been
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been planned or expected to be done: “everything”,
“more than half “, “less than half” or “nothing”. The
analysis of HALT offsets those who had done less
than half against those who had done more than half,
counting the former as doing nothing and the latter
as doing everything [9, 14].
Statistics and analyses
Data were entered into a secure database and statistical
analyses were performed using EPI INFO [22] and SPSS
version 15.
We used proportions (%) to report prevalences, with
95 % confidence intervals (CIs) when appropriate. We
used means, with standard deviations (SDs) and/or
standard errors (SEs), and medians to summarise the
distributions of continuous variables. Headache intensity
responses “not bad”, “quite bad” and “very bad” were
equated to “mild”, “moderate” and “severe” and con-
verted to a numerical rating scale 1–3, which we treated
as continuous data. We used Fisher’s exact test for sig-
nificance of differences. We set the level of significance
at p < 0.05.
We calculated the predicted 1-day prevalence of any
headache and of headache types from the 1-year preva-
lence and estimated mean frequency (F) in days/year
(extrapolated from the last 3 months) using the formula:
1−day prevalence ¼ 1−year prevalence  F=365
We calculated total lost productivity as a proportion
(%), the numerator being the sum of those reporting
nothing or less than half done and the denominator the
number (N) who reported HY.
Results
There were 2329 participants (1141 [49.0 %] male, 1188
[51.0 %] female; mean age 38.0 [±12.7] years; 1103
[47.4 %] from rural areas, 1226 [52.6 %] urban). The par-
ticipation proportion was 92.6 % (eligible population n =
2514). The distributions of gender, age and habitation in
the participating sample have been described in detail
previously and were comparable to those of the popula-
tion of Karnataka [19]. As reported previously, the 1-
year prevalence of any headache was 63.9 %; the age-
standardised 1-year prevalence of migraine was 25.2 %
and of TTH was 35.1 %; the age-standardised prevalence
of all causes of headache on ≥15 days/month was 3.0 %
and of pMOH was 1.2 % [5].
Headache yesterday
HY was reported by 138 participants, representing a 1-day
prevalence of headache of 5.9 %. The predicted 1-day
prevalence of any headache calculated from its 1-yearprevalence of 63.9 % and estimated mean frequency of
32.0 days/year [5] was 5.6 %, a very close match.
HY was reported by over three times as many females
(8.8 %) as males (2.9 %) (Table 1). Reporting of HY var-
ied with age, but with wide and overlapping confidence
intervals. Almost three quarters of HY (73.9 %) was re-
ported by rural participants, despite that they made up
less than half (47.4 %) of the participating sample. These
data are also shown in Table 1.
HY was reported to be typical of their usual most
bothersome (diagnosed) headache by only 95 (68.8 %) of
those with HY. This limited the inferences we could
draw about HY diagnostically. Among these 95 only, we
could make reasonable assumptions as to diagnosis; on
these, we based calculations of predicted 1-day preva-
lences by headache type (Table 2). There was an exact
match for migraine and a close match for pMOH; TTH
and other headache on ≥15 days/month were underre-
ported yesterday, and may have been preferentially
among the cases of HY not considered typical of the
usual most bothersome headache. For all HY, as noted
above, there was a good match.
Mean duration of HY was 7.0 ± 8.5 h. From this we
calculated that 1.7 % of the population (5.9 % * 7.0/24),
on average, had headache at any moment in time yester-
day. The median was 3 h; therefore HY was quite short-
lasting in more than half of cases. If this reflected usage
of acute medications, these were taken by 46.3 % of par-
ticipants with HY–that is, 2.5 % of the total survey sam-
ple. By implication this meant that, on any day, 2.5 %
of the adult population were using acute medication
for headache. A further 36.9 % used local applications
of various sorts, including 4.3 % who used both medi-
cation and local applications. Headache intensity was
severe in 29.7 %, moderate in 46.4 % and mild in
23.9 %. Mean intensity on a scale of 1–3 was there-
fore 2.0 [±0.8] (SE: 0.07).
Lost productivity due to HY was reported to some de-
gree by 83.3 % of participants with HY: 37.7 % had been
able to do less than half of what they had planned and
13.0 % could do nothing. Applying the concept behind
the analysis of HALT (see Methods [14]), we found that
HY cost those affected by HY half (50.7 %) of their prod-
uctivity yesterday. We looked at this by diagnosis in
those for whom we had diagnostic information (Table 3).
This analysis indicated that migraine cost much more
lost productivity than TTH (p = 0.048 [Fisher’s exact,
2-tailed]), while pMOH eclipsed even migraine (but
with small numbers, p = 0.75). To calculate the prod-
uctivity loss due to HY at population level we multi-
plied 50.7 % by the overall prevalence of HY of
5.9 %; this gave an estimate of 3.0 % as the product-
ivity loss within the entire adult population, every
single day, attributable to headache.
Table 1 Characteristics of participants reporting headache yesterday (HY) and population prevalence of HY by group (N = 2329)
Characteristic Reported cases of HY
in defined group
n (%)
N in defined group Population prevalence
of HY in defined group
(%) [95 % CI]
All cases of HY 138 (100.0) 2329 5.9 [5.0–7.0]
Gender
Male 33 (24.0) 1141 2.9 [2.1–4.0]
Female 105 (76.0) 1188 8.8 [7.4–10.6]
Age (years)
<25 18 (13.0) 353 5.1 [3.3–7.9]
25 to 34 35 (25.4) 627 5.6 [4.0–7.7]
35 to 44 41 (29.7) 603 6.8 [5.1–9.1]
45 to 54 23 (16.7) 409 5.6 [3.8–8.3]
55 to 65 21 (15.2) 337 6.2 [4.1–9.3]
Habitat
Rural 102 (73.9) 1103 9.3 [7.7–11.1]
Urban 36 (26.1) 1226 2.9 [2.1–4.0]
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The principal finding was a 1-day prevalence of head-
ache of 5.9 %, with the implication that this propor-
tion of the adult population (one in 17) had headache
on each and every day. Mean duration of HY was 7.0 ±
8.5 h, so that 1.7 % of the population (5.9 % * 7.0/24), on
average, had headache at any moment in time yesterday
(and, again by implication, at any moment on any day).
Mean intensity on a scale of 1–3 was 2.0. Lost
productivity was reported by most (83.3 %) partici-
pants with HY, of whom 37.7 % could do less than
half of what they had planned and 13.0 % could
do nothing. Productivity loss due to HY at popula-
tion level (being the productivity loss within the
entire adult population, every single day, attribut-
able to headache) was 3.0 %.
The large difference in prevalence of HY between rural
(9.3 %) and urban populations (2.9) was in part
explained by the higher rural 1-year prevalence ofTable 2 Prevalence of headache yesterday according to diagnosis (w
comparison with predicted 1-day prevalence based on reported freq
Headache type Headache yesterday:
with diagnosis (N = 95) or all case
n (%) Observed 1-d
prevalence (%
Migraine 44/95 (46.3 %) 1.
Tension-type headache 23/95 (24.2 %) 1.
Probable medication-overuse headache 13/95 (13.7 %) 0.
Other headache on ≥15 days/month 15/95 (15.8 %) 0.
Unknown headache yesterday 43/138 1.
All headache yesterday 138 5.
aFrom reference [5]
bFrom reference [18]headache (71.2 % versus 57.3 %), thought to be due to
adverse rural socioeconomic conditions (diet, stress and
relative poverty) [5]. In addition, the poor rural availabil-
ity and utilization of health-care facilities were likely to
contribute to more frequent headache and therefore
more HY. Probable MOH was more prevalent in rural
(1.5 %) than in urban areas (0.9 %) [5]; because of its
high frequency, this disorder is a major contributor to
HY despite its low prevalence.
It is a limitation of enquiry into HY that diagnosis can-
not reliably be based on a single headache episode; un-
less a respondent is able to assert that HY was typical of
a recurrent headache that has been diagnosed, its nature
will not be known. In this survey, only two thirds could
do this, with the result that our inferences on headache
types, as opposed to all headache, are unavoidably con-
strained. From a public-health perspective this may not
be of great importance; the key messages here emphasise
the ubiquity of headache, its frequency, its symptomhen recognized as most bothersome headache), and
uency and 1-year prevalence
s (N = 138)
Predicted 1-day prevalence
ay







9 25.2 28 b 1.9
0 35.1 17 b 1.6
6 1.2 226 b 0.7
6 1.8 259 b 1.3
8 - - -
9 63.9 32.0 a 5.6 a
Table 3 Lost productivity because of headache yesterday according to diagnosis (when recognized as most bothersome headache)






Probable MOH Other headache
on ≥15 days/month
N reporting headache yesterday (X) 44 23 13 15 138
Could do nothing at all (n) (Y) 6 1 2 2 18
Could do less than half (n) (Z) 20 6 7 3 52
Estimated lost productivity
yesterday ([Y + Z]/X) (%)
60.5 30.4 69.2 33.3 50.7
MOH medication-overuse headache
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type, and its impact at population level (3.0 % loss of
productivity).
This is the fourth published analysis of HY, following
those in China [15], eight countries of Europe [17] and
Russia [16]. Comparison with Russia is of most interest
because headache prevalences in China are much lower
[23] and the data from the Eurolight study were not en-
tirely population-based [24]. In Russia, 14.5 % of partici-
pants, also aged 18–65 years, reported HY [16]. This
much higher proportion (14.5 % versus 5.9 %) reflected a
lower prevalence of migraine in Russia than in Karna-
taka (20.3 % versus 25.2 %) and lower prevalence of
TTH (30.9 % versus 35.1 %), but a much higher preva-
lence of headache on ≥15 days/month (10.5 % versus
3.0 %) [5, 25]. As noted above, high-frequency headache
has a dominant influence on HY.
The mean duration of HY of 7 h in Karnataka com-
pared with 6 h in Russia, where there was a higher rate
of medication use [16]. While we calculated that 1.7 %
of the adult population in Karnataka had headache at
any moment in time, in Russia, the proportion was
much higher (3.6 % [16])–more than double. However,
China reported a very similar 1.8 % [15]. In terms of
pain intensity, the mean of 2.0 on a scale of 1–3 was
much the same as the 2.1 reported in Russia [16], and
expected to be disabling. The consequences were seen in
the per-person lost productivity of 50.7 % and
population-level lost productivity of 3.0 %. Per-person
lost productivity was lower in Russia, at 39.8 %, but, with
the higher prevalence, population-level lost productivity
attributed to HY was quite a lot higher than in Karna-
taka, at 5.8 % [16]. Notwithstanding this, the 3.0 % losses
in Karnataka represent a major socioeconomic drain.
While 5.9 % of participants reported HY in Karnataka,
this number was closely corroborated by the predicted
1-day prevalence of headache of 5.6 %. In all three earl-
ier published studies of HY, similar internal consistency
has been seen between reported HY and prediction of 1-
day headache prevalence based on estimated 1-year
prevalence and recalled frequency during the preceding
3 months [15–17]. What was underestimated in recallover 3 months was the productivity loss, which was cal-
culated at population level in Karnataka at only 1.8 %
[18])–seemingly a major error. Similar underestimates in
recall were reported in Russia [16].
The crucial question, which has been raised before [5, 18],
is whether and to what extent these findings are represen-
tative of this culturally and environmentally very diverse
country and can, therefore, be extrapolated to all India.
The truth is that we do not know: we have drawn atten-
tion to the need for at least one further similar study in
the country, perhaps in the north, seeking corroboration
[18]. In the meantime, we reiterate that these are the best
data available for the country. If it is the case that 1.7 % of
the Indian adult population (approximately 14 million
people), or anything in the region of this number, have
disabling headache at every moment, this signals a press-
ing need to do something about it: cost-effective treat-
ments are available [26]. At the least, the further study we
have called for should be commissioned urgently. The do-
nothing option is not cost-free: it incurs the estimated
3.0 % lost productivity, which is likely to be reflected in a
correspondingly diminished gross domestic product. It
should be noted that this survey was conducted among
the population aged 18–65 years: ie, those of working age,
among whom productivity losses have most impact on the
population economy. The cost is therefore huge.
The strengths of our study were several. Enquiry into
headache yesterday is a powerful approach to population-
based burden-of-headache studies, virtually eliminating
recall error and any bias that may follow from this [9].
Our sample was large and representative, and the non-
participation proportion was low (7.4 %) [5, 19]. Through
cold-calling and face-to-face interviews, we avoided the
previously described bias of “headache today” [17]: partici-
pants with headache on the day they receive a question-
naire by post may defer responding until the first day of
headache-freedom, and then spuriously report HY.
Conclusions
Using HY as a method of enquiry free from recall error,
we have confirmed a very high level of headache-
attributed burden in Karnataka. Previous estimates based
Steiner et al. The Journal of Headache and Pain  (2016) 17:74 Page 6 of 6on 3-month recall [18] may even have been too low.
Until another study is done in the country, these are the
best data for all India. We repeat our call for action, re-
iterating that correct action will ultimately almost cer-
tainly be cost-saving [27].
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